Live Breaking News & Updates on Medical division new

Stay informed with the latest breaking news from Medical division new on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Medical division new and stay connected to the pulse of your community

Viking Therapeutics (NASDAQ:VKTX) Raised to "Sell" at StockNews.com

StockNews.com upgraded shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) to a sell rating in a report issued on Thursday morning. A number of other equities analysts have also weighed in on the company. Oppenheimer upped their price objective on Viking Therapeutics from $116.00 to $138.00 and gave the stock an outperform rating in a […]

United-states , Massachusetts , American , William-blair , Sarah-kathryn-rouan , Charles-schwab-investment-management-inc , American-century-companies-inc , Therapeutics-inc , Maxim-group , Goldman-sachs-group-inc , Securities-exchange-commission , Massachusetts-financial-services-co

XOMA's (XOMA) Buy Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of XOMA (NASDAQ:XOMA – Free Report) in a report issued on Thursday morning, Benzinga reports. They currently have a $74.00 target price on the biotechnology company’s stock. XOMA Stock Up 0.2 % XOMA stock opened at $25.41 on Thursday. The firm has a market cap of $295.77 […]

United-states , Asia-pacific , Securities-exchange-commission , Barclays-plc , Company-profile , Nasdaq , Free-report , Get-free-report , Xoma , Nasdaq-xoma , Medical , 98419j10

Align Technology (NASDAQ:ALGN) Rating Reiterated by Piper Sandler

Piper Sandler reiterated their overweight rating on shares of Align Technology (NASDAQ:ALGN – Free Report) in a report issued on Thursday morning, Benzinga reports. The firm currently has a $375.00 target price on the medical equipment provider’s stock, up from their prior target price of $355.00. Other equities research analysts have also issued reports about […]

United-states , Switzerland , Emory-wright , Leerink-partnrs , Piper-sandler , Robertw-baird , News-ratings-for-align-technology-daily , Technology-company-profile , Hedge-funds-weigh-in-on-align-technology , Technology-inc , Technology-stock-performance , Valley-national-advisers-inc

Thermo Fisher Scientific (NYSE:TMO) Given New $615.00 Price Target at Barclays

Thermo Fisher Scientific (NYSE:TMO – Free Report) had its price objective hoisted by Barclays from $590.00 to $615.00 in a report issued on Thursday, Benzinga reports. They currently have an equal weight rating on the medical research company’s stock. A number of other research firms have also recently weighed in on TMO. The Goldman Sachs […]

United-states , America , Robertw-baird , Marcn-casper , Sanfordc-bernstein , Citigroup , Barclays , Pineridge-advisors , Lifesteps-financial-inc , Life-sciences-solutions , Goldman-sachs-group

Robert W. Baird Raises Align Technology (NASDAQ:ALGN) Price Target to $370.00

Align Technology (NASDAQ:ALGN – Free Report) had its price objective boosted by Robert W. Baird from $333.00 to $370.00 in a research note released on Thursday, Benzinga reports. Robert W. Baird currently has an outperform rating on the medical equipment provider’s stock. Other equities research analysts have also recently issued research reports about the company. […]

Switzerland , United-states , Emory-wright , Stifel-nicolaus , Robertw-baird , Leerink-partnrs , Technology-company-profile , Hedge-funds-weigh-in-on-align-technology , News-ratings-for-align-technology-daily , York-mellon-corp , Checchi-capital-advisers , Nasdaq

Analysts Set United Therapeutics Co. (NASDAQ:UTHR) Target Price at $294.25

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price objective among […]

United-states , Leerink-partnrs , Livforsakringsbolaget-skandia-omsesidigt , Christopher-patusky , Paula-mahon , United-therapeutics-company-profile , United-therapeutics-corporation , United-therapeutics-co , Securities-exchange-commission , Sg-americas-securities , Nasdaq , Goldman-sachs-group

Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives $17.85 Average Target Price from Brokerages

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fifteen ratings firms that are covering the company, MarketBeat.com reports. Six analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year price objective among […]

Christopherr-cline , Zurcher-kantonalbank-zurich-cantonalbank , Piper-sandler , Travere-therapeutics-company-profile , Nasdaq , Cheyne-capital-management-united-kingdom , Emerald-mutual-fund-advisers , Sg-americas-securities , Emerald-advisers , Wells-fargo-company , Travere-therapeutics-inc , Travere-therapeutics

Brokerages Set Envista Holdings Co. (NYSE:NVST) Price Target at $29.60

Shares of Envista Holdings Co. (NYSE:NVST – Get Free Report) have received a consensus recommendation of “Reduce” from the eleven ratings firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and two have issued a buy recommendation on […]

China , United-states , William-blair , Asset-management , Envista-holdings-corporation , Envista-company-profile , Envista-holdings-co , Nuance-investments , Franklin-resources-inc , Jefferies-financial-group , Vanguard-group-inc , Norges-bank

Contrasting InnovAge (NASDAQ:INNV) and Accelera Innovations (OTCMKTS:ACNV)

InnovAge (NASDAQ:INNV – Get Free Report) and Accelera Innovations (OTCMKTS:ACNV – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends and institutional ownership. Insider and Institutional Ownership 12.3% of InnovAge shares are […]

California , United-states , Denver , Colorado , Chicago , Illinois , Colorado-springs , New-mexico , Pennsylvania , Virginia , Accelera-innovations-inc

AstraZeneca PLC (NASDAQ:AZN) Forecasted to Post FY2025 Earnings of $5.12 Per Share

AstraZeneca PLC (NASDAQ:AZN – Free Report) – Analysts at Leerink Partnrs lifted their FY2025 earnings per share (EPS) estimates for shares of AstraZeneca in a research report issued to clients and investors on Wednesday, April 24th. Leerink Partnrs analyst A. Berens now anticipates that the company will post earnings of $5.12 per share for the […]

Leerink-partnrs , Sage-rhino-capital , Jefferies-financial-group , Mitchell-pahl-private-wealth , Astrazeneca , Deutsche-bank-aktiengesellschaft , Pinnacle-associates-ltd , Mesirow-financial-investment-management-inc , Morgan-stanley , Investment-counsel-inc , Free-report , Bank-aktiengesellschaft